Selective Estrogen Receptor Modulators (SERMs) undoubtedly are a cornerstone of pharmaceutical PCT interventions. They functionality as aggressive inhibitors at estrogen receptors in the hypothalamus whilst exhibiting tissue-selective agonist or antagonist Qualities through the system. SERMs are very important in regulating post cycle estrogen prod